Phil Trans. R. Soc. Lond. B 307, 309-312 (1984) [ 309 New genes composed of the mouse metallothionein I promoter-regulator and the rat or human growth hormone structural gene have been introduced into mice. A large proportion of mice containing these genes express them, and some animals grow to be up to twice as large as controls. The technique has been used in part to correct the genetic defect that results in the small stature of the mutant little mouse. thymidine kinase (TK) structural gene were expressed in 70 % of the animals in which they had integrated into the chromosomes (Palmiter et al. I982a) . Success with this gene suggested several other possible experiments employing fusion genes. For one of these series of studies, we fused the MT promoter to the rat growth hormone (rGH) structural gene (Palmiter et al. i982b) . When this construction was introduced into mice, a large proportion of animals containing the new gene grew faster and larger than littermate controls without the new gene. Some of these transgenic animals reached twice the normal size. For instance, in the line of animals shown in figure 1, every animal containing the gene grew faster and larger than littermate controls. The new gene was transmitted to half the progeny, which suggests integration into a single chromosome. Furthermore, the gene was expressed in the progeny in a manner similar to that observed in the parent (unpublished observations). This pedigree has been extended to the fifth generation, and it is clear that the gene has become stably integrated into the chromosomes. Whether this gene or other transferred genes will be subject to greater mutation rate or loss than endogenous DNA can only be determined by continued breeding.
For several reasons a fusion gene consisting of the MT promoter-regulator and the human growth hormone gene was constructed (Palmiter et al. I983) . Although considerable homology exists between the mouse and rat growth hormone genes, the human hormone differs from the mouse hormone in 67 of 191 amino acids. None the less, animals containing the MT promoter-regulator fused to the human growth hormone (hGH) gene grew faster and became larger than controls to the same degree as animals with MT-rGH genes. Human GH appeared just as effective as rat GH in binding to mouse cell receptors and inducing a physiological response. In these studies we were able to measure accurately the message produced in several tissues by the MT-hGH gene and the endogenous MT gene. The MT gene is expressed in most tissues and provides an ideal control mRNA level against which to compare the mRNA levels from the foreign fusion gene containing the same promoter-regulator. Several important observations can be made from these experiments (Palmiter et al. I 983) . First, the message levels from the MT-hGH gene are lower than from the MT gene in all tissues. Second, a hierarchy of MT-hGH relative to MT gene expression exists, with the MT-hGH message levels being closest to MT levels in the liver while MT-hGH message levels in kidney, intestine, brain, spleen, and lung are much lower than MT message levels. Third, in certain tissues of some animals, message levels from the new gene are much higher than expected on the basis of levels seen in the same tissue of other animals with the gene, suggesting that integration has occurred in these animals in a region of chromatin that facilitates or allows a higher level of expression (Palmiter et al. I 983) .
In experiments done during the past two years, we have attempted to correct the genetic defect known as little (lit/lit) by gene transfer (Hammer et al. I984 ). This mutant is characterized by small stature (one-half normal size) and poor reproductive performance. These animals contain an intact growth hormone gene, but have decreased levels of growth hormone mRNA in the pituitary and growth hormone in the serum. Following introduction of the MT-rGH gene, mutant little mice grow faster than lit/lit mice and reach a size three times that of their mutant control littermates (figure 2). Thus the growth defect can be corrected by gene transfer. However, GH is not regulated by the normal hypothalamic control mechanism, and the animals thus grow larger than even normal mice. The mutant males, which are relatively infertile, become more fertile when they express the MT-rGH gene. However mutant females, which are normally fertile, become more infertile when they express the MT-rGH gene. In fact, we have noted reduced fertility in most female mice that produce elevated levels of GH from either the MT-rGH or MT-hGH gene (Hammer et al. 1984) . The manner in which elevated growth hormone affects fertility is unknown but might reflect the result of an endocrine inbalance. Mouse on left is a male mutant little mouse weighing 12 g. On the right is a male littermate weighing 32 g that has inherited the MT-rGH gene from the father of both mice. The gene had been injected into the pronucleus of the egg from which the father developed. The father was large and was mated to a homozygous mutant lit/lit mouse to produce these two littermates. The new gene results in a marked increase in size when it is present in this line of animals even though they are homozygous for the lit/lit gene.
Transgenic animals provide an important new experimental tool to examine gene expression in vivo. The studies described with growth hormone fusion genes are one example of how this system may be used.
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